Ani pharmaceuticals reports second quarter 2021 results

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (“ani” or the “company”) (nasdaq: anip) today announced business highlights and financial results for the three and six months ended june 30, 2021. second quarter and recent business highlights: the company refiled its supplemental new drug application (“snda”) for cortrophin® gel with the u.s. food and drug administration (“fda” or the “agency”) on june 29, 2021; goal date is october 29, 2021; acquisition of novitium pharma llc (“novi
ANIP Ratings Summary
ANIP Quant Ranking